Age, Family history, FIGO Stage, Serous Carcinoma and Ki-67 were considered statistically significant different (P<0.05) in training cohort, but just family history and Ki-67 were considered statistically significant different (P<0.05) in both training and validation cohorts. The gene discussed is MKI67; the disease is serous adenocarcinoma.